On March 28, 2025, Bio-Path Holdings, Inc. entered into a securities purchase agreement to issue a promissory note worth $100,050 for $87,000, with a 12% interest rate and specific payment terms. The note can convert to shares under certain conditions, and it is not registered under securities laws.